Innocare Pharma

Innocare Pharma's reported carbon emissions

In 2023, Innocare Pharma reported total carbon emissions of approximately 12,134,540 kg CO2e, comprising 19,950 kg CO2e from Scope 1 and about 12,114,590 kg CO2e from Scope 2 emissions. This marks an increase from 2022, when total emissions were approximately 9,835,800 kg CO2e, all attributed to Scope 2, as there were no Scope 1 emissions recorded that year. Innocare Pharma has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company has not disclosed any Scope 3 emissions data, which includes emissions from purchased goods and services, indicating a potential area for future reporting and improvement. Overall, Innocare Pharma's emissions profile highlights a reliance on indirect emissions from energy consumption, with a significant focus on Scope 2 emissions. The company is encouraged to establish clear climate commitments and reduction strategies to enhance its sustainability efforts.